Richard K. Suzuki

Short Term Culture of Human Mesenchymal Stem Cells with Commercial Osteoconductive Carriers Provides Unique Insights into Biocompatibility

C. Chaput, C. Gregory, M. Murphy, 2013, Journal of clinical medicine.

Autologous bone marrow concentrate intradiscal injection for the treatment of degenerative disc disease with three-year follow-up

K. Pettine, M. Murphy, R. Suzuki, 2017, International Orthopaedics.

Autologous bone marrow concentrate (bmc) for the treatment of osteoarthritis (o.a) of the knee, hip, and shoulder in former n.f.l. players

K. Pettine, Kathryn Moncivais, Meghana Malur, 2018 .

Percutaneous Injection of Autologous Bone Marrow Concentrate Cells Significantly Reduces Lumbar Discogenic Pain Through 12 Months

K. Pettine, M. Murphy, Theodore T. Sand, 2015, Stem cells.

Treatment of discogenic back pain with autologous bone marrow concentrate injection with minimum two year follow-up

K. Pettine, M. Murphy, Theodore T. Sand, 2015, International Orthopaedics.

Viable Stem Cells Are in the Injury Effusion Fluid and Arthroscopic Byproducts From Knee Cruciate Ligament Surgery: An In Vivo Analysis.

J. Andrews, Adam W Anz, M. Murphy, 2017, Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association.

Inhibition of Inflammatory Species by Titanium Surfaces

J. Frangos, R. Suzuki, Richard K. Suzuki, 2000, Clinical orthopaedics and related research.

Surface Interaction of Inflammatory Species with Titanium and Titanium Oxide

J. Frangos, J. McKittrick, G. Hirata, 1998 .

Reactive oxygen species inhibited by titanium oxide coatings.

J. Frangos, J. McKittrick, J. Muyco, 2003, Journal of biomedical materials research. Part A.

Increased Internal Porosity and Surface Area of Hydroxyapatite Accelerates Healing and Compensates for Low Bone Marrow Mesenchymal Stem Cell Concentrations in Critically-Sized Bone Defects

M. Murphy, Eileen Dawson, Melissa A. Samano, 2018, Applied Sciences.

Treatment of discogenic back pain with autologous bone marrow concentrate injection with minimum two year follow-up

K. Pettine, M. Murphy, Theodore T. Sand, 2015, International Orthopaedics.